Trading Tech Stocks; Tech Stock News and daily Podcasts

Friday, January 14, 2022

New #Stocks to Watch at Investor Ideas: (Nasdaq: $BFRI) (Nasdaq: $CGTX) (Nasdaq: $EXAI) (CSE: $PBF.C) (CSE: $STGX.C) (CSE: $MJEM.C)

New #Stocks to Watch at Investor Ideas: (Nasdaq: $BFRI) (Nasdaq: $CGTX) (Nasdaq: $EXAI) (CSE: $PBF.C) (CSE: $STGX.C) (CSE: $MJEM.C)

#Biotech, #Mining, #Plant-Based and #Tech Stocks to Watch

Point Roberts WA, Delta BC, January 14, 2022 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Biotech, Mining, Plant-Based and Tech. Today’s stocks have been added to our lists of free stock directories in each sector.

Read this in full at https://www.investorideas.com/news/2022/main/01141Stocks.asp

The newest biotech companies are involved in treatments of dermatological conditions, CNS and cancer among other diseases.

The latest mining company is focused on cobalt and ‘green metals’, while the newest plant-based company offers a vegan meat alternative derived from hemp.

The newest tech company is a social media company for Generation Z’s.

New stocks added to the Biotech Stock Directory:

Biofrontera Inc. (Nasdaq: BFRI) is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.

COGNITION THERAPEUTICS INC (Nasdaq: CGTX) is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system, or CNS, and retina. Our goal is to develop disease modifying treatments for patients with these degenerative disorders by initially leveraging our expertise in the σ-2 (sigma-2) receptor, or S2R, which is expressed by multiple cell types, including neuronal synapses, and acts as a key regulator of cellular damage commonly associated with certain age-related degenerative diseases of the CNS and retina. We believe that targeting the S2R complex represents a mechanism that is functionally distinct from other current approaches in clinical development for the treatment of degenerative diseases.

Exscientia Ltd. (Nasdaq: EXAI) is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our pipeline of internal and partnered programmes demonstrates our ability to rapidly translate scientific concepts into precision-designed therapeutic candidates, with more than 25 projects advancing, including the first three AI-designed drug candidates to enter Phase 1 clinical trials. Exscientia has offices in Oxford, Vienna, Dundee, Miami, Boston, and Osaka

IO Biotech, Inc. (Nasdaq: IOBT) is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on its T-win® technology platform. The T-win® platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. IO Biotech is advancing its lead immuno-oncology candidate, IO102-IO103, targeting IDO and PD-L1, in clinical studies and its other pipeline candidates through clinical and preclinical development. IO Biotech is headquartered in Copenhagen, Denmark, and has additional offices within the United States (New York, New York and Rockville, Maryland) and United Kingdom (Monmouthshire).

LianBio (NasdaqGM:LIAN) is a cross-border biotechnology company on a mission to bring transformative medicines to historically underserved patients in China and other Asian markets. Through partnerships with highly innovative biopharmaceutical companies around the world, LianBio is advancing a diversified portfolio of clinically validated product candidates with the potential to drive new standards of care across cardiovascular, oncology, ophthalmology, inflammatory disease and respiratory indications. LianBio is establishing an international infrastructure to position the company as a partner of choice with a platform to provide access to China and other Asian markets.

MiNK Therapeutics, Inc. (Nasdaq: INKT) is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. MiNK is advancing a pipeline of both native and next-generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Pyxis Oncology, Inc. (Nasdaq PYXS) is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. Pyxis develops its product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Since its launch in 2019, Pyxis has developed a broad portfolio of novel antibody drug conjugate, or ADC, product candidates, and monoclonal antibody, or mAb, preclinical discovery programs that it is developing as monotherapies and in combination with other therapies.

Theseus Pharmaceuticals, Inc. (Nasdaq:THRX) is a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. Theseus is developing next-generation tyrosine kinase inhibitors (TKIs): "pan-variant" targeted therapies that address all major drug resistance mutations. Theseus' lead product candidate, THE-630, is a pan-variant KIT inhibitor for the treatment of patients with advanced gastrointestinal stromal tumors (GIST), whose cancer has developed resistance to earlier lines of kinase inhibitor therapy. Theseus is also developing a fourth-generation, selective epidermal growth factor receptor (EGFR) inhibitor for C797S-mediated resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer (NSCLC).

Vaxxinity, Inc. (NasdaqGM:VAXX) is purpose-driven biotechnology company committed to democratizing healthcare across the globe. The company is pioneering a new class of synthetic, peptide-based immunotherapeutic vaccines aimed at disrupting the existing treatment paradigm for chronic disease, increasingly dominated by monoclonal antibodies, which suffer from prohibitive costs and cumbersome administration. The company’s proprietary technology platform has enabled the innovation of novel pipeline candidates designed to bring the efficiency of vaccines to the treatment of chronic diseases, including Alzheimer’s, Parkinson’s, migraine, and hypercholesterolemia. The technology is also implemented as part of a COVID-19 vaccine program. Vaxxinity has optimized its pipeline to achieve a potentially historic, global impact on human health.

New stocks added to the Mining Stocks Directory:

StrategX Elements Corp. (CSE:STGX) is an exploration company poised to be a significant contributor in the green energy sector and emerging low carbon economy. The Company is currently focused on discovery of cobalt and associated ‘green’ metals in northern Canada. The Company’s property portfolio includes two new regional plays: Project 939 & EA South situated near the shores of the East Arm of the Great Slave Lake, Northwest Territories, and Project M on the Melville peninsula, Nunavut, also located close to tidewater.

New stocks added to the Plant-Based Stocks Directory:

Planet Based Foods Global Inc. (CSE:PBF) is focused on producing natural, low processed and nutritional choices that are better for people and the planet. The Company currently offers a high quality, cost-efficient vegan meat alternative derived from hemp proteins including burgers, breakfast sausages, burger crumbles and sausage crumbles.

New stocks added to the Tech Stocks Directory:

Mijem Newcomm Tech Inc. (CSE:MJEM) is a social media and technology company providing innovative solutions to create a vibrant social marketplace for Generation Z communities, such as students, to connect and to efficiently buy, sell and trade goods and services on and off campus.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast.

Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining and the AI Eye.

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

Download our Mobile App for iPhone and Android

Join our Investor Club https://www.investorideas.com/membership/

Contact Investorideas.com

800 665 0411

Wednesday, January 12, 2022

#AIEye #Podcast 647: #Stocks discussed: (NYSE: $IBM) (NYSE: $JCI) #artificialintelligence

#AIEye #Podcast 647: #Stocks discussed: (NYSE: $IBM) (NYSE: $JCI) #artificialintelligence

IBM Expands AI Software with Envizi Acquisition, and Johnson Controls Acquires Edge AI Developer FogHorn

Global Call Center #AI Market to Reach $9.94B by 2030

Point Roberts WA, Vancouver BC – January 12, 2022 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2022/011222-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2022/artificial-intelligence/01121IBM-JCI.asp

Hear the Ai Eye on Spotify

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NYSE:IBM) (NYSE:JCI)

IBM (NYSE:IBM) has announced the acquisition of Envizi, described in the press release as “a leading data and analytics software provider for environmental performance management.” By integrating Envizi with IBM’s other AI-powered softwares, companies will be able to “automate the feedback generated between their corporate environmental initiatives and the operational endpoints being used in daily business operations.” Kareem Yusuf, General Manager, IBM AI Applications, explained:

"To drive real progress toward sustainability, companies need the ability to transform data into predictive insights that help them make more intelligent, actionable decisions every day. Envizi's software provides companies with a single source of truth for analyzing and understanding emissions data across the full landscape of their business operations and dramatically accelerates IBM's growing arsenal of AI technologies for helping businesses create more sustainable operations and supply chains."

Smart buildings leader Johnson Controls International (NYSE:JCI) has acquired FogHorn, a major developer of Edge AI software for the industrial and commercial Internet of Things (IoT) solutions. The integration of FogHorn’s Edge AI software with Johnson Controls’ OpenBlue smart buildings platform will enable machine-learning-driven solutions to streamline building maintenance. Johnson Controls CTO Vijay Sankaran said:

"Value is increasingly being created by applying intelligence at the edge-device level to create real-time, secure, actionable insights. By pervasively integrating Foghorn's world class Edge AI throughout our OpenBlue solution portfolio, we are accelerating the pace towards our vision of smart, autonomous buildings that continuously learn, adapt and automatically respond to the needs of the environment and people."

Global Call Center AI Market to Reach $9.94B by 2030

A report published by Allied Market Research finds that the global Call Center AI market will grow from $959.8 million USD in 2020 to $9.94 billion by 2030, registering a compound annual growth rate (CAGR) of 26.3 percent in the forecast period 2021-2030. An excerpt from the report overview outlines some key influences on the market’s growth:

The global call center AI market is impacted by factors such as rise in need for improved customer experience & customer response time along with the enhanced data analytical capabilities. Moreover, high installation and training cost coupled with privacy and security concerns is affecting the call center AI market growth. Furthermore, rise in focus of companies in AI technology and increase in penetration of social media platforms influence the market growth. However, each of these factors is anticipated to have a definite impact on the growth of the global market during the forecast period.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.

About Investorideas.com - News that Inspires Big Investing Ideas

The Investorideas.com podcasts are also available on Apple Podcasts , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com

Download our Mobile App for iPhone and Android

Join our Investor Club https://www.investorideas.com/membership/

Contact Investorideas.com

800 665 0411

Get more Technology stock investor ideas - news, articles, podcasts and stock directories

Tuesday, January 11, 2022

#Technology #Stock News: GBT (OTCPK: $GTCH) is Developing an Internet Based Licensing System to Potentially Offer its Microchip Analysis Technology through a Secured Web Portal Interface

#Technology #Stock News: GBT (OTCPK: $GTCH) is Developing an Internet Based Licensing System to Potentially Offer its Microchip Analysis Technology through a Secured Web Portal Interface

SAN DIEGO - January 11, 2022 (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCH) ("GBT" or the "Company"), is developing an Internet based system to potentially license its microchip analysis technology through a web portal interface.

Read this news, featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2022/01111Internet-Based-Licensing-System.asp

Using a secured portal, fabless IC design firms will be able to license and use GBT's IC analysis programs per demand. This system will potentially offer an affordable solution for small and medium integrated design companies that cannot afford mass licensing model costs. Typically, these types of software are licensed based on the number of users, and in case of large corporations via a site license model. This method may not be affordable to many small and medium size IC design firms. Establishing a per-demand, per-user license leasing feature may open new business opportunities for many IC design houses around the world.

GBT, upon completion of the portal, plans to offer a wide variety of IC analysis and verification programs within the fields of Design Rule Check, Reliability, Electrical Connectivity, and DFM (Design for Manufacturing). Once developed, the secured web portal will offer the option of analysis run on the customer's machines or on GBT's secured servers with the goal of correcting and/or improving the microchip's characteristics and confirming the desired outcome. Corporations will be able to license GBT's software tools per session and usage period; for example, per week, month or more. The licensing cost will be calculated according to usage time, number of users and the leased software tools. In the past decade the IC's industry has experienced high demand for computer-aided-design (CAD), also called EDA (Electronic Design Automation), software tools as these become key aspects in transforming product's definition and concepts into production-ready integrated circuits. GBT intends to make its technology available for all IC design firms sizes enabling them to achieve their goals and introduce their projects to market in an affordable manner.

"Large microchip design companies typically pay millions of dollars annually to license a complete set of EDA tools that are necessary to design IC projects; particularly, in advanced nanometer nodes. But not every design firm can afford this cost. For example, startups or medium size corporations are struggling paying high licensing cost of EDA tools to ensure well designed projects. Using a per-demand, per user licensing model, we plan to offer our IC analysis technology in much more affordable prices. As large corporations will be able to license our technology according to their capabilities, smaller and medium firms will also benefit from advanced IC analytics tools in an affordable cost. We plan to offer this type of licensing through a secured web portal that will provide time/user based, per-demand leasing option. Design firms will have the option to run GBT's software on their own servers or to upload their design to be processed on our secured computing environment. We will offer our Design Rule, Reliability, Connectivity and DFM analysis tools. We plan to incorporate advanced data security technology to protect design firm's IP and analysis results. We firmly believe that such a system may create a whole world of business opportunities, offering significant productivity enhancement technology, enabling a major project's design time reduction, with higher quality, and much faster timelines to market" stated Danny Rittman, the Company's CTO.

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) ("GBT") (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT's mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT's goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT's vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

Contact:

Dr. Danny Rittman, CTO
press@gopherprotocol.com

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

Get News Alerts on GBT Technologies Inc GTCH

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Get more tech stocks investor ideas- news, articles, podcasts and stock directories

About Investorideas.com

About Investorideas.com - Big Investing Ideas Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

Discclaimer /disclosure

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com